Xiulian DU,Janos LUKA,Lewis Joe STAFFORD,Mark Semenuk,Xue-Ping WANG,Judith KANTOR,Andrew BRISTOL
申请号：
US16205288
公开号：
US20190322720A1
申请日:
2018.11.30
申请国别(地区):
US
年份:
2019
代理人:
摘要：
This invention relates to NPC-1 antigen on the MUC5AC protein and 16C3 antigen on CEACAM5 and CEACAM6 proteins, and 31.1 epitope on the A33 protein are differentially expressed in cancers including, lung cancer, ovarian cancer, pancreas cancer, breast cancer, and colon cancer, and diagnostic and therapeutic usages. Further, NPC-1, 16C3, and/or 31.1 epitope specific antibodies and diagnostic and therapeutic methods of use.
